As of 2026-05-09, the EV/EBITDA ratio of Lotus Pharmaceuticals Inc (LTUS) is
0.45.
EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. LTUS's latest enterprise value
is 5.36 mil USD. LTUS's TTM EBITDA according to its financial statements is
12.00 mil USD. Dividing these 2
quantities gives us the above LTUS EV/EBITDA ratio.
|
Range |
Selected |
| Trailing P/E multiples |
9.4x - 13.5x |
11.6x |
| Forward P/E multiples |
12.8x - 16.6x |
14.6x |
| Fair Price |
3.87 - 17.43 |
10.10 |
| Upside |
107296.0% - 484048.7% |
280331.4% |